Valerio Therapeutics(DE:C4X)
€0.48+-0.01 (+3.26%)
DE:C4X
Valerio Therapeutics financials statements
€0.48
At close:+-0.01 (+3.26%)
Valerio Therapeutics (C4X) Income Statement
0 Followers
Valerio Therapeutics Income Statement
Last quarter (Q2 2026), Valerio Therapeutics's total revenue was €3.10M, an increase of 3385.39% from the same quarter last year. In Q2, Valerio Therapeutics's net income was €-2.36M. See Valerio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 2.57M | € 1.79M | € 1.80M | € 1.44M | € 4.06M | |
| € 1.73M | € 1.28M | € 1.27M | € 929.00K | € 3.69M | |
| € 2.28M | € 17.77M | € 21.55M | € 17.66M | € 8.84M | |
| Depreciation and Amortization | € 4.90M | € 11.31M | € 507.00K | € 33.00K | € 511.00K |
| € 542.00K | € -12.06M | € -19.68M | € -17.08M | € -5.86M | |
| € -550.00K | € -16.49M | € -20.29M | € -17.11M | € -7.33M | |
| € -4.09M | € -7.06M | € -39.00K | € -2.16M | € -255.00K | |
| € -4.64M | € -23.55M | € -20.33M | € -19.27M | € -7.58M | |
| € -4.90M | € -23.93M | € -20.34M | € -19.56M | € -5.94M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.03 | € -0.16 | € -0.15 | € -0.18 | € -0.07 |
| Diluted EPS | € -0.03 | € -0.16 | € -0.15 | € -0.18 | € -0.07 |
| Weighted Average Shares Outstanding | 154.36M | 153.88M | 135.63M | 105.75M | 88.21M |
| Weighted Average Shares Outstanding (Diluted) | 154.36M | 153.88M | 135.63M | 105.75M | 88.21M |
Currency in EUR
